AKT1 and neoplasm: showed that galectin-1 is elevated in sorafenib-resistant HCC cells, both in vitro and in vivo, promoting tumor metastasis and increasing tumor invasion, suggesting that galectin-1 plays a role in downstream regulation of the AKT/mTOR/HIF-1 signaling pathway (113).